Biomarkers Predicting Progression of HIV Disease
Author Information
Author(s): Kanekar Amar
Primary Institution: East Stroudsburg University of Pennsylvania
Hypothesis
The review aims to address changes in biomarker studies related to HIV disease progression over the last five years.
Conclusion
There have been advancements in biomarker studies, but many novel biomarkers need further evaluation and replication in larger trials.
Supporting Evidence
- Biomarkers such as CD4 counts and C-reactive protein are associated with HIV disease progression.
- Newer markers like soluble Toll-like receptors are being studied for their predictive value.
- Validation of biomarkers in larger trials is necessary for clinical acceptance.
Takeaway
Scientists are studying different markers in the blood to see how they can tell if someone with HIV will get sick with AIDS. Some new markers are promising, but we need to test them more.
Methodology
A systematic review of studies published between 2002-2008 was conducted using the PUBMED database, focusing on articles related to biomarkers and AIDS.
Limitations
Many biomarkers need validation in larger trials, and some studies were experimental.
Participant Demographics
Adult population, studies published in English.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website